|
656796db212eaade2e0ee108
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013857
|
01KI1824
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.22377
|
0
|
0
|
0
|
0.22377
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Advancing CRISPR antimicrobial...s to combat the bacterial pathogen Klebsiella pneumoniae - Medical research of particular importance for developing countries - infectious disease abatement
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796db212eaade2e0ee109
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013858
|
01KI1825
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.148456
|
0
|
0
|
0
|
0.148456
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
SCAN - Design and validation o...f a theranostic siderophore conjugate platform against Gram-negative, clinically relevant bacterial pathogens - Medical research of particular importance for developing countries - infectious disease abatement
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796dc212eaade2e0ee10a
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013859B
|
01KI1827B
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.136684
|
0
|
0
|
0
|
0.136684
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
RESET-ME - Restoring E. coli s...ensitivity for antibiotics by blocking TolC-mediated efflux - Proteins and electrophysiology - Medical research of particular importance for developing countries
more
|
0
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796dc212eaade2e0ee10b
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013861
|
01KI1829
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.018907
|
0
|
0
|
0
|
0.018907
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
IRAADO - Establishing an inter...national research network to identify and develop novel antibiotics - Medical research of particular importance for developing countries
more
|
0
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796dc212eaade2e0ee10c
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013862
|
01KI1830
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.027706
|
0
|
0
|
0
|
0.027706
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Bridging the gap between humAn... and animal suRveillance data, antibiotic poliCy and stewardsHip (ARCH) - Medical research of particular importance for developing countries
more
|
0
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796dc212eaade2e0ee10d
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013853
|
01KI1815
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.059577
|
0.026477
|
0
|
0
|
0.059577
|
0.026477
|
|
0
|
|
0.059577
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
INFECTION
|
Infection
|
Networking project - Influence... of vector-host relationship on virus transmission efficiency - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796dd212eaade2e0ee10e
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014217K
|
16GW0164K
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.328075
|
0
|
0
|
0
|
0.328075
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Medical research of particular... importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796dd212eaade2e0ee10f
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014218
|
16GW0165
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.180094
|
0
|
0
|
0
|
0.180094
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Medical research of particular... importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796dd212eaade2e0ee110
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014219
|
16GW0166
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.056974
|
0
|
0
|
0
|
0.056974
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Medical research of particular... importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796dd212eaade2e0ee111
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014220
|
16GW0167
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.195786
|
0
|
0
|
0
|
0.195786
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Medical research of particular... importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796dd212eaade2e0ee112
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014221
|
16GW0168
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.105983
|
0
|
0
|
0
|
0.105983
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Medical research of particular... importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796dd212eaade2e0ee113
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014222
|
16GW0169
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.007306
|
0
|
0
|
0
|
0.007306
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Medical research of particular... importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
61009
|
Other non-financial corporatio...ns
more
|
Other non-financial corporatio...ns
more
|
|
|
|
656796dd212eaade2e0ee114
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014223
|
16GW0206
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.087328
|
0
|
0
|
0
|
0.087328
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Medical research of particular... importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796de212eaade2e0ee115
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014224
|
16GW0212
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.061626
|
0
|
0
|
0
|
0.061626
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Development of non-immunosuppr...essive FK506 analogs as Mip inhibitors for the treatment of Legionella pneumophila, Burkholderia pseudomallei and Trypanosoma cruzi infections - Development of FK506 analogs as Mip inhibitors for the treatment of Trypanosoma cruzi infections - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796de212eaade2e0ee116
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014225K
|
16GW0227K
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.106896
|
0
|
0
|
0
|
0.106896
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Pre-clinical development of Co...rallopyronin A – an antibiotic active against helminths, STIs and Staphylococci (Corals) – Non-GLP pre-clinics - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796de212eaade2e0ee117
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014226
|
16GW0228
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.229994
|
0
|
0
|
0
|
0.229994
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Pre-clinical development of Co...rallopyronin A (Corals) – an antibiotic active against helmionths, STIs and Staphylococci – Production of HQ-RGM CorA - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796de212eaade2e0ee118
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014227
|
16GW0229
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.084786
|
0
|
0
|
0
|
0.084786
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Pre-clinical development of Co...rallopyronin A - an antibiotic active against helminths, STIs and Staphylococci / CorA formulation and bioanalytics - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796de212eaade2e0ee119
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014228K
|
16GW0253K
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.355145
|
0.105983
|
0
|
0
|
0.355145
|
0.105983
|
|
0
|
|
0.355145
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Validation of the confirmed ¿...-glutamylspermine synthetase GlnA3 as a target for development of novel anti-tubercular drugs - Characterization of GlnA3Mt in polyamine metabolism - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796de212eaade2e0ee11a
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014229
|
16GW0254
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.33756
|
0.039886
|
0
|
0
|
0.33756
|
0.039886
|
|
0
|
|
0.33756
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Joint project - Validation of... the confirmed ¿-glutamylspermine synthetase GlnA3 as a target for development of novel anti-tubercular drugs / Sub project - Relevance of the ¿-glutamylspermine synthetase GlnA3 for successful growth inhibition of M. tuberculosis - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796de212eaade2e0ee11b
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014230
|
16GW0255
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.371352
|
0.067722
|
0
|
0
|
0.371352
|
0.067722
|
|
0
|
|
0.371352
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Target-Validierung - Validatio...n of the confirmed ¿-glutamylspermine synthetase GlnA3 as a target for development of novel anti-tubercular drugs (GSS-TUBTAR) - Development of spermine analogs as GlnA3Mt inhibitors - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796df212eaade2e0ee11c
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014231K
|
16GW0281K
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.434297
|
0.043709
|
0
|
0
|
0.434297
|
0.043709
|
|
0
|
|
0.434297
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Target validation - Exotic PKA... Signaling in Parasites (ParaKill) Validation of inhibitors for Chagas Disease, Leishmaniosis and Sleeping Sickness - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796df212eaade2e0ee11d
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014232
|
16GW0282
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.386174
|
0.025286
|
0
|
0
|
0.386174
|
0.025286
|
|
0
|
|
0.386174
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Target validation - Exotic PKA... Signaling in Parasites-Validation of inhibitors for Chagas Disease, Leishmaniosis and Sleeping Sickness (ParaKill) - Design and Synthesis of PKA-Inhibitors - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796df212eaade2e0ee11e
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014233
|
16GW0283
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.113805
|
0.018567
|
0
|
0
|
0.113805
|
0.018567
|
|
0
|
|
0.113805
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
RESEARCH IN ACTIVE SUBSTANCES ...- PHARMACEUTICAL RESEARCH
more
|
Research in active substances ...- pharmaceutical research
more
|
Target validation - Exotic PKA... Signaling in Parasites (ParaKill) - Synthesis of building blocks and lead compounds - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796df212eaade2e0ee11f
|
2020
|
Germany
|
City State of Hamburg
|
2020014369
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
6.444071
|
6.444071
|
0
|
0
|
6.444071
|
6.444071
|
|
6.444071
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
BERNHARD NOCHT INSTITUTE FOR T...ROPICAL MEDICINE (BNITM)
more
|
Bernhard Nocht Institute for T...ropical Medicine (BNITM)
more
|
Research, teaching, training a...nd further education as well as consulting and health care in the fields of infectious and tropical medicine. The Bernhard Nocht Institute for Tropical Medicine (BNITM) is Germany's largest institution for research, treatment and training in the field of tropical diseases and new emerging infections. As a member of the Leibniz-Association and as a research institute of national importance, the Institute is jointly funded by the Federal Government, the Free and Hanseatic City of Hamburg and the other federal states. Research topics include clinical studies, epidemiology and disease control as well as the biology of pathogens, their reservoirs and vectors. The current scientific focus is on malaria, haemorrhagic fever viruses, immunology, epidemiology and clinical studies of tropical infections as well as on the mechanisms of the viral transmission by mosquitoes.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think-tank
more
|
|
|
|
656796df212eaade2e0ee120
|
2020
|
Germany
|
Federal Ministry of Health
|
2020012879
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
11.121867
|
11.121867
|
0
|
0
|
11.121867
|
11.121867
|
|
11.121867
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
BERNHARD-NOCHT-INSTITUT FÜR T...ROPENMEDIZIN (BNITM)
more
|
Bernhard-Nocht-Institut für T...ropenmedizin (BNITM)
more
|
Research, teaching, training a...nd further education as well as consulting and health care in the fields of infectious and tropical medicine. The BNITM is Germany's largest institution for research, treatment and training in the field of tropical diseases and new emerging infections. As a member of the Leibniz-Association and as a research institute of national importance, the Institute is jointly funded by the Federal Government, the Free and Hanseatic City of Hamburg and the other federal states. Research topics include clinical studies, epidemiology and disease control as well as the biology of pathogens, their reservoirs and vectors. The current scientific focus is on malaria, haemorrhagic fever viruses, immunology, epidemiology and clinical studies of tropical infections as well as the optimization of control measures against tropical infectious diseases in resource-poor countries and the mechanisms of virus transmission by mosquitoes.For the handling of highly pathogenic viruses and infected insects, the Institute has laboratories of the highest biosafety level (BSL-4) and a BSL-3 insectary. The Institute's health care services include specific laboratory diagnostics of tropical diseases and other rare infections, capacity building as well as the consultation of the scientific community, politics and the general public, which essentially contribute to the Institute's national reputation. The Institute has been appointed by the Federal Ministry of Health as the National Reference Center (NRC) for the detection of all tropical pathogens as well as by the WHO as Collaborating Center for arboviruses and haemorrhagic fever viruses. In collaboration with the Ghanaian Health Ministry and the University of Kumasi the Institute has been operating a modern research and training center in the West-African rain forest for over twenty years, which is also available to external research groups.The teaching activities comprise a three months full-time course on all aspects of tropical medicine for physicians as well as a training program for PhD students at the Institute and a number of activities on continuing education in topics related to travel medicine and international health. Numerous scientists of the Institute are involved in student teaching as appointed professors of the University and the University Hospital of Hamburg.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think-tank
more
|
|
|
|
656796df212eaade2e0ee121
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013824
|
01KA1617
|
3
|
Eastern Africa, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.176607
|
0
|
0
|
0
|
0.176607
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Evaluation of an antibody dete...cting point-of-care test for the diagnosis of Taenia solium taeniosis and (neuro)cysticercosis in communities and primary care settings of highly endemic, resource-poor areas in Tanzania and Zambia, including training of - and technology transfer to the Regional Reference Laboratory and health centres - Research funding / knowledge transfer / advanced training / capacity building in education and research in developing country
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796df212eaade2e0ee122
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013840
|
01KA1920
|
1
|
Gabon
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.913331
|
0.058588
|
0
|
0
|
0.913331
|
0.058588
|
|
0
|
|
0.913331
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
A Multicenter Study of the Imm...unogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSVdeltaG-ZEBOV GP) for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebola Virus Exposure (PREPARE-GERMANY) - Medical research of particular importance for developing countries - infectious disease abatement
more
|
Ebola
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e0212eaade2e0ee123
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013866
|
01KI1910
|
1
|
Gambia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.410139
|
0.038194
|
0
|
0
|
0.410139
|
0.038194
|
|
0
|
|
0.410139
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
K-STaR - A K-mer based approac...h for institutional AMR Surveillance, Transmission monitoring, and Rapid diagnostics - Medical research of particular importance for the developing country, capacity building in education and research in medical research
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e0212eaade2e0ee124
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013723B
|
01DQ16011B
|
3
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.021393
|
0
|
0
|
0
|
0.021393
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Multiplexed, label-free Fiber ...optic Biosensor array system for Waterborne Pathogen Detection - Research to improveon livelihoods in the developing country which are affected by environmental change and marine pollution
more
|
0
|
14030
|
Basic drinking water supply an...d basic sanitation
more
|
|
I.4. Water Supply & Sanitation
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e0212eaade2e0ee125
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013743
|
01DQ19001
|
3
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.073718
|
0
|
0
|
0
|
0.073718
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Collaborative project - Develo...pment of meta-genome-based tools for monitoring antibiotic resistance in river bodies – a study in the Ganges river valley, sub-project - Bioinformatics - Medical research of particular importance for developing countries - infectious disease abatement
more
|
0
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e0212eaade2e0ee126
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013756
|
01DQ20002
|
1
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.169946
|
0.013816
|
0
|
0
|
0.169946
|
0.013816
|
|
0
|
|
0.169946
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Collaborative project - Tracki...ng antimicrobial resistance and efficiency of malaria diagnostics in tribal areas of India to achieve elimination goals, sub-project - Methodological redevelopment and statistical evaluations - Medical research of particular importance for the developing country, capacity building in education and research in medical research
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e0212eaade2e0ee127
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013759
|
01DQ20005
|
1
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.1687
|
0.002279
|
0
|
0
|
0.1687
|
0.002279
|
|
0
|
|
0.1687
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Collaborative project - Determ...ination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections, sub-project - microscopic biofilm assays and image analysis - Medical research of particular importance for the developing country, capacity building in education and research in medical research
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e0212eaade2e0ee128
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013761
|
01DQ20007
|
1
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.170939
|
0.038746
|
0
|
0
|
0.170939
|
0.038746
|
|
0
|
|
0.170939
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Collaborative project - Novel ...Efflux Pump Inhibitors for Restoring E. coli Sensitivity for Antibiotics, sub-project - Experimental validation and evaluation - Medical research of particular importance for the developing country, capacity building in education and research in medical research
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e0212eaade2e0ee129
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014098
|
031L0125
|
3
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.056445
|
0
|
0
|
0
|
0.056445
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
INDIVIDUALIZED MEDICINE
|
Individualized medicine
|
Immunometabolic Networks in th...e Regulation of Visceral Leishmaniasis - Medical research of particular importance for developing countries
more
|
NTDs
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e1212eaade2e0ee12a
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014213
|
16GW0105
|
3
|
Indonesia
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.027335
|
0
|
0
|
0
|
0.027335
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Collaborative project - German...-Indonesian Aniinfective Cooperation (GINAICO), subproject - Characterization of the antiviral activity of natural compounds in biological sources in Indonesia - Medical research of particular importance for developing countries
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e1212eaade2e0ee12b
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014214
|
16GW0106
|
3
|
Indonesia
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.054981
|
0
|
0
|
0
|
0.054981
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Collaborative project - German...-Indonesian Aniinfective Cooperation (GINAICO), subproject - Application of novel microbiological and ecological methods for the discovery of novel antimicrobial natural substances in marine invertebrates and their associated microorganisms - Medical research of particular importance for developing countries
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e1212eaade2e0ee12c
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014215
|
16GW0123
|
3
|
Indonesia
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.001863
|
0
|
0
|
0
|
0.001863
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Collaborative project - Indone...sian Plant Biodiversity and Human Health (BIOHEALTH), subproject - Metabolic analysis - Medical research of particular importance for developing countries
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e1212eaade2e0ee12d
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020014216K
|
16GW0124K
|
3
|
Indonesia
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.009152
|
0
|
0
|
0
|
0.009152
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Collaborative project - Isolat...ion of New Unique Natural Compounds from Unknown Actinomycetes (NAbaUnAkt), subproject - Identification and manipulation of antibiotic synthesis gene clusters in unknown actinomycetes - Medical research of particular importance for developing countries
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e1212eaade2e0ee12e
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013512
|
01DK17039
|
3
|
Kyrgyzstan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.074074
|
0
|
0
|
0
|
0.074074
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Kyrgyz-German Hepatitis B Init...iative - Creation of a sustainable binational infrastructure for epidemiological and vaccine research - Medical research of particular importance for developing countries
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e1212eaade2e0ee12f
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013842
|
01KA1922
|
1
|
Madagascar
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.068369
|
0.014637
|
0
|
0
|
0.068369
|
0.014637
|
|
0
|
|
0.068369
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
ESTHER - Digitization of epide...miological tuberculosis surveillance systems in Madagascar - Medical research of particular importance for developing countries - infectious disease abatement
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e2212eaade2e0ee130
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013595A
|
01DN18006A
|
3
|
Mexico
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.182336
|
0
|
0
|
0
|
0.182336
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COOPERATION WITH FOREIGN RESEA...RCH INSTITUTIONS (NOT INCLUDED IN OTHER AREAS)
more
|
Cooperation with foreign resea...rch institutions (not included in other areas)
more
|
Collaborative project - Cost-e...ffective, microfluidic point-of-care platform for the detection of vector-borne diseases in Latin America, sub-project - Technology development - Medical research of particular importance for developing countries
more
|
0
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e2212eaade2e0ee131
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013595B
|
01DN18006B
|
3
|
Mexico
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.072493
|
0
|
0
|
0
|
0.072493
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
FUNDING FOR SCIENTIST EXCHANGE...S, GRANTS
more
|
Funding for scientist exchange...s, grants
more
|
Collaborative project - Cost-e...ffective, microfluidic point-of-care platform for the detection of vector-borne diseases in Latin America, sub-project - Molecular biology development - Medical research of particular importance for developing countries
more
|
0
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e2212eaade2e0ee132
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013443
|
01DH17046
|
3
|
Morocco
|
North of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.000938
|
0
|
0
|
0
|
0.000938
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Collaborative Project - Isolat...ion and characterization of anti-infective secondary metabolites from microorganisms of Moroccan habitats, Sub-project - Halle-Wittenberg University - Research funding / knowledge transfer / advanced training / capacity building in education and research in developing country
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e2212eaade2e0ee133
|
2020
|
Germany
|
Federal State of Bavaria
|
2020014987
|
F.4-V0122.4/2/20
|
1
|
South Africa
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
3.104558
|
1.740901
|
0
|
0
|
3.104558
|
1.740901
|
|
3.104558
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
BTZ-043-A NEW ANTIBIOTIC TO CO...MBAT TUBERCULOSIS
more
|
BTZ-043-a new antibiotic to co...mbat tuberculosis
more
|
Development BTZ-preparation re...gistration studies after preclinical development of the drug
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e2212eaade2e0ee134
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013588
|
01DN17032
|
3
|
South America, regional
|
South America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.029042
|
0
|
0
|
0
|
0.029042
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SCIENTIFIC COOPERATION WITH OT...HER COUNTRIES (NOT INCLUDED IN OTHER AREAS)
more
|
Scientific cooperation with ot...her countries (not included in other areas)
more
|
Hostpathogen interactions in... MultidrugResistant Tuberculosis (MDRTB) - Study of the Molecular Epidemiology, Host Immune Responses and GenomeBased Prediction and Early Identification of MDRTB in High Tuberculosis Burden Settings - Medical research of particular importance for developing countries
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e2212eaade2e0ee135
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013593
|
01DN18001
|
3
|
South America, regional
|
South America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.021198
|
0
|
0
|
0
|
0.021198
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COOPERATION WITH FOREIGN RESEA...RCH INSTITUTIONS (NOT INCLUDED IN OTHER AREAS)
more
|
Cooperation with foreign resea...rch institutions (not included in other areas)
more
|
Collaborative Project - Target...ing Lipoic Acid Salvage and Biosynthesis Pathways in MRSA, sub-project - Computational Chemistry (Computer-based identification and optimizing of suicide substrates and enzyme inhibitors) - Medical research of particular importance for developing countries - infectious disease abatement
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e2212eaade2e0ee136
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013643
|
01DN19014
|
3
|
South America, regional
|
South America
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.04822
|
0
|
0
|
0
|
0.04822
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COOPERATION WITH FOREIGN RESEA...RCH INSTITUTIONS (NOT INCLUDED IN OTHER AREAS)
more
|
Cooperation with foreign resea...rch institutions (not included in other areas)
more
|
ERA-Net collaborative projekt ...- Diagnosis and surveillance of vectorborne viruses and hemoparasites across the humanwildlife interface in the Amazon Basin, Sub-project - Health #1 - Infectious diseases - Early detection research including both screening and diagnosis - Medical research of particular importance for developing countries - infectious disease abatement
more
|
0
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e3212eaade2e0ee137
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013402
|
01DG18024
|
3
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.104008
|
0
|
0
|
0
|
0.104008
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COOPERATION WITH FOREIGN RESEA...RCH INSTITUTIONS (NOT INCLUDED IN OTHER AREAS)
more
|
Cooperation with foreign resea...rch institutions (not included in other areas)
more
|
Collaborative project - Long-t...erm Europe-Africa Reseach Network on neglected arboviral zoonotic disease, sub- project - FLI - Medical research of particular importance for the developing country, capacity building in education and research in medical research
more
|
0
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Teaching institution/Research ...and development institute
more
|
|
|
|
656796e3212eaade2e0ee138
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013821_L
|
01KA1612_L
|
3
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.028589
|
0
|
0
|
0
|
0.028589
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Research networks for health i...nnovation in Filariasis and Podoconiosis Disease Control. TAKoFF will focus on the prophylaxis, diagnostic (incl. staging) and therapy of filarial lymphedema. The Munich-part of the consortium will primarily study HIV/LF confected individuals to address the question, whether an antiretroviral treatment will increase the risk or filarial induced pathology. - Medical research of particular importance for developing countries
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
|
656796e3212eaade2e0ee139
|
2020
|
Germany
|
Federal Ministry of Education ...and Research
more
|
2020013821_N
|
01KA1612_N
|
3
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.027577
|
0
|
0
|
0
|
0.027577
|
|
0
|
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
COMMON DISEASES
|
Common diseases
|
Research networks for health i...nnovation in Filariasis and Podoconiosis Disease Control. TAKoFF will focus on the prophylaxis, diagnostic (incl. staging) and therapy of filarial lymphedema. The Munich-part of the consortium will primarily study HIV/LF confected individuals to address the question, whether an antiretroviral treatment will increase the risk or filarial induced pathology. - Medical research of particular importance for developing countries
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Higher education institution
|
|
|
